Belgium – Medical equipment, pharmaceuticals and personal care products – Supply of continuous interstitial glucose monitoring (CGM) systems, including sensors, readers and associated services

Opportunity description

This public contract aims to regulate the supply of continuous interstitial glucose monitoring systems for the care of adult patients with diabetes in Belgium, whether they fall under Group A (e.g.: insulin-dependent type 1 diabetes, requiring intensive monitoring) or Group B (e.g.: insulin-dependent or non-insulin-dependent type 2 diabetes, or combination treatment, requiring less intensive monitoring). Implantable sensors requiring surgery are excluded from this contract. Systems that cannot operate autonomously and necessarily require connection to an insulin pump are also excluded. Continuous interstitial glucose monitoring (CGM) systems, including sensors, readers and associated services for Group A beneficiaries. Continuous interstitial glucose monitoring (CGM) systems, including sensors, readers and associated services for Group B beneficiaries. Procedure: neg-w-call. Review the original TED notice for the complete requirement, lots, amendments and attachments.